Trinity Biotech Statistics
Total Valuation
TRIB has a market cap or net worth of $12.31 million. The enterprise value is $103.18 million.
Important Dates
The last earnings date was Friday, November 15, 2024, before market open.
Earnings Date | Nov 15, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
TRIB has 9.47 million shares outstanding. The number of shares has increased by 23.79% in one year.
Current Share Class | n/a |
Shares Outstanding | 9.47M |
Shares Change (YoY) | +23.79% |
Shares Change (QoQ) | -0.00% |
Owned by Insiders (%) | 6.68% |
Owned by Institutions (%) | 11.78% |
Float | 4.79M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.21 |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.75 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.64
Current Ratio | 1.64 |
Quick Ratio | 0.87 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1.39 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -8.19% |
Return on Capital (ROIC) | -11.28% |
Revenue Per Employee | $155,595 |
Profits Per Employee | -$53,511 |
Employee Count | 380 |
Asset Turnover | 0.73 |
Inventory Turnover | 1.78 |
Taxes
Income Tax | -102,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.01% in the last 52 weeks. The beta is 1.13, so TRIB's price volatility has been higher than the market average.
Beta (5Y) | 1.13 |
52-Week Price Change | -32.01% |
50-Day Moving Average | 1.55 |
200-Day Moving Average | 2.05 |
Relative Strength Index (RSI) | 34.98 |
Average Volume (20 Days) | 164,635 |
Short Selling Information
Short Interest | 94,129 |
Short Previous Month | 122,247 |
Short % of Shares Out | 2.43% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.43 |
Income Statement
In the last 12 months, TRIB had revenue of $59.13 million and -$20.33 million in losses. Loss per share was -$2.15.
Revenue | 59.13M |
Gross Profit | 21.13M |
Operating Income | -10.55M |
Pretax Income | -21.51M |
Net Income | -20.33M |
EBITDA | -8.65M |
EBIT | -10.55M |
Loss Per Share | -$2.15 |
Full Income Statement Balance Sheet
The company has $2.84 million in cash and $93.72 million in debt, giving a net cash position of -$90.88 million or -$9.60 per share.
Cash & Cash Equivalents | 2.84M |
Total Debt | 93.72M |
Net Cash | -90.88M |
Net Cash Per Share | -$9.60 |
Equity (Book Value) | -26.34M |
Book Value Per Share | -2.78 |
Working Capital | 18.03M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$7.30 million and capital expenditures -$498,000, giving a free cash flow of -$7.80 million.
Operating Cash Flow | -7.30M |
Capital Expenditures | -498,000 |
Free Cash Flow | -7.80M |
FCF Per Share | -$0.82 |
Full Cash Flow Statement Margins
Gross margin is 35.74%, with operating and profit margins of -17.84% and -34.39%.
Gross Margin | 35.74% |
Operating Margin | -17.84% |
Pretax Margin | -34.56% |
Profit Margin | -34.39% |
EBITDA Margin | -14.63% |
EBIT Margin | -17.84% |
FCF Margin | n/a |